SPT Antibodies

Santa Cruz Biotechnology offers a broad range of SPT Antibodies for studying SPT (serine palmitoyltransferase), a key enzyme involved in sphingolipid metabolism. SPT Antibodies enable multiple research applications including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). SPT plays a crucial role in the synthesis of sphingolipids, which are essential components of cell membranes and are involved in various cellular processes, including signaling, differentiation, and apoptosis. Dysregulation of SPT has been linked to several diseases, including neurodegenerative disorders and cancer, making it a significant target for therapeutic research. Understanding SPT function and regulation provides valuable insights into cellular metabolism and disease mechanisms. Research into SPT activity helps reveal new therapeutic approaches for treating disorders related to sphingolipid imbalances. Investigating SPT pathways advances knowledge of membrane biology and cell signaling networks. SPT research using Santa Cruz Biotechnology monoclonal antibodies contributes to breakthrough discoveries in cell biology and disease treatment.